2[1]Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells[J]. Science, 1999, 284(5411): 143-7.
3[2]Caplan AI. Mesenchymal stem cells and gene therapy[J]. Clin Or thop, 2000, 379(Suppl): S67-70.
4[3]Perin EC, Dohmann HF, Borojevic R, et al. Transendocardial, autol ogous bone marrow cell transplantation for severe, chronic ischemic heart failure[J]. Circulation, 2003, 107(18): 2294-302.
5[4]Britten MB, Abolmaali ND, Assmus B, et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute my ocardial infarction (TOPCARE-AMI): mechanistic insights from se rial contrast-enhanced magnetic resonance imaging [ J ]. Circulation, 2003, 108(18): 2212-8.
6[5]Fuchs S, Satler LF, Komowski R, et al. Catheter-based autologous bone marrow myocardial injection in no-option patients with ad vanced coronary artery disease: a feasibility study [J]. J Am Coll Cardiol, 2003, 41(10): 1721-4.
7[6]Meinel L, Karageorgiou V, Fajardo R, et al. Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow[J]. Ann Biomed Eng, 2004, 32(1): 112-22.
8[10]Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine[J ]. Muscle Nerve, 1995, 18(12): 1417-26.
9[11]Makino S, Fukuda K, Miyoshi S, et al. Cardiomyocytes can be gen erated from marrow stromal cells in vitro [J]. J Clin Invest, 1999, 103(5):697-705.
10[12]Hassink RJ, Brutel de la Riviere A, Mummery CL, et al. Transplan tation of cells for cardiac repair[ J]. J Am Coll Cardiol, 2003, 41(5): 711-7.
